[ad_1]
Palo Alto, Calif.–(ANTARA/Enterprise Wire)- Guardant Well being, Inc. (NASDAQ:GH), a number one precision oncology firm, at this time introduced it has bought the remaining shares of Guardant Well being AMEA, Inc., held by SoftBank and its associates, giving the corporate full management over operations all through the Asia, Center East and Africa area.
Greater than half of the world’s estimated new most cancers circumstances come from Asia, Center East and Africa (AMEA).1 This acquisition will enable Guardant Well being to immediately handle the rising most cancers burden within the area by accelerating the adoption of the corporate’s blood assessments and companies utilized by healthcare suppliers to detect and handle most cancers throughout all phases of the illness.
Guardant Well being AMEA operations help 41 international locations throughout the area. Close to time period, the corporate will prioritize bringing blood-based testing to healthcare suppliers and to sufferers with superior most cancers in Japan, the place, in March 2022, the Japanese Ministry of Well being, Labour and Welfare (MHLW) granted regulatory approval of Guardant360® CDx, a liquid biopsy check for tumor mutation profiling in sufferers with superior stable tumors.
“By buying the remaining shares of Guardant Well being AMEA, we are able to deal with making a unified and centralized world group that delivers on our promise to assist conquer most cancers and enhance affected person outcomes,” stated Helmy Eltoukhy, Guardant Well being chairman and co-CEO. “We consider our blood-based assessments can play a big position in serving to handle the rising incidence of most cancers within the area, and we stay up for persevering with to help sufferers going through most cancers diagnoses as we broaden our operations in these markets.”
In Could 2018, Guardant Well being and SoftBank Imaginative and prescient Fund established the Guardant Well being AMEA three way partnership to broaden commercialization of Guardant Well being’s industry-leading liquid biopsy expertise throughout the area. Below the phrases of the events’ three way partnership settlement, Guardant Well being paid roughly $177.8 million to amass the Guardant Well being AMEA fairness curiosity held by SoftBank and its associates.
About Guardant Well being
Ahead-Trying Statements
This press launch incorporates forward-looking statements inside the which means of federal securities legal guidelines, together with statements concerning the potential utilities, values, advantages and benefits of Guardant Well being’s liquid biopsy assessments or assays, which contain dangers and uncertainties that might trigger the precise outcomes to vary materially from the anticipated outcomes and expectations expressed in these forward-looking statements. These statements are based mostly on present expectations, forecasts and assumptions, and precise outcomes and outcomes may differ materially from these statements as a consequence of a lot of components. These and extra dangers and uncertainties that might have an effect on Guardant Well being’s monetary and working outcomes and trigger precise outcomes to vary materially from these indicated by the forward-looking statements made on this press launch embrace these mentioned beneath the captions “Threat Elements” and “Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operation” and elsewhere in its Annual Report on Kind 10-Ok for the 12 months ended December 31, 2021 and in its different stories filed with the Securities and Trade Fee. The forward-looking statements on this press launch are based mostly on data obtainable to Guardant Well being as of the date hereof, and Guardant Well being disclaims any obligation to replace any forward-looking statements offered to mirror any change in its expectations or any change in occasions, circumstances, or circumstances on which any such assertion is predicated, besides as required by regulation. These forward-looking statements shouldn’t be relied upon as representing Guardant Well being’s views as of any date subsequent to the date of this press launch.
References
Contacts
Investor Contact:
Alex Kleban
+1 657-254-5417
Media Contact:
Michele Relaxation
+1 215-910-2138
Supply: Guardant Well being, Inc.
[ad_2]
Source link